News Daily News ACC: It’s Time for Clinicians to Address Inflammation in CVD Caitlin E. Cox October 03, 2025
News Conference News ACC 2025 Cardiologists Plot Next Moves After New Board Rejected Yael L. Maxwell April 11, 2025
News Features AEDs, Like Fire Extinguishers, Should Be in Every School, Say Experts Michael O'Riordan February 19, 2025
News Conference News PCR London Valves 2024 Residual TR After Treating Mitral ViV Disease Linked to Worse Outcomes Michael O'Riordan November 26, 2024
News Conference News TCT 2024 SIRONA: Sirolimus and Paclitaxel DCBs Offer Similar Patency, Function in PAD L.A. McKeown October 29, 2024
News Conference News TCT 2024 TRILUMINATE: More Patient Data Reassure on TEER’s Benefits for Severe TR Michael O'Riordan October 29, 2024
News Daily News SCAI Releases Practical, Technical Advice for Primary PCI in STEMI Michael O'Riordan October 10, 2024
News Features Initial US Commercial TriClip Cases Offer Hope, but Reimbursement Still a Big Question L.A. McKeown August 09, 2024
News Daily News Schoolwide Intervention May Improve Obesity Outcomes Over Time Yael L. Maxwell July 29, 2024
News Daily News Knowns and Unknowns in Subclinical Aortic Valve Thrombosis Caitlin E. Cox June 21, 2024
News Conference News EuroPCR 2024 SWIFT TAVI Algorithm Lowers Wait Times for Highest-Risk Patients Yael L. Maxwell May 16, 2024
News Conference News ACC 2024 Coronary Sinus Reducer Eases Symptoms in Refractory Angina: ORBITA-COSMIC Michael O'Riordan April 08, 2024
News Opinion Off Script Evoque and Patisiran: A Tale of Two Regulatory Journeys Sanjay Kaul, MD March 29, 2024
News Daily News Mechanism’s Mojo: ‘Obvious’ CV Therapies More Likely to Be Seen as Effective Michael O'Riordan February 23, 2024
News Daily News FDA Advisors Set to Take on TriClip for TR as TRILUMINATE Questions Loom Michael O'Riordan February 09, 2024
News Daily News FDA Approves First Transcatheter Tricuspid Valve Replacement Device L.A. McKeown February 02, 2024
News Daily News TCT Abstract Ranking Reveals Global CVD Research Hot Spots L.A. McKeown November 21, 2023